Nevakar has secured $20 million in financing to accelerate its pipeline projects, which include ophthalmic and injectable products, the company announced in a press release.
The senior secured term loan is with Oxford Finance LLC, and an additional $10 million will be provided when predefined milestones are met.
“We are delighted to enter into this agreement with Oxford Finance as we seek to continue to fund and advance our lead product candidates, including NVK-002 that is currently in a phase 3 clinical trial for children with myopia,” Navneet Puri, PhD, (Read more...)
Uncategorized